Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P62988 (
Ubiquitin
)
4,326
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ubiquitin
-positive Lewy neurites and Lewy bodies are found in idiopathic Parkinson's disease (PD) and diffuse Lewy body disease (DLBD). We found that, in three patients with PD and one with DLBD, microtubule-associated protein 5 (MAP5) immunostaining was consistently present in both Lewy neurites and Lewy bodies throughout the brainstem and forebrain regions affected in the disease. In contrast, other cytoskeletal markers (neurofilaments and
MAP2
) could be demonstrated in only a small fraction of Lewy bodies and neurites. Confocal microscopy demonstrated that MAP5 immunolabeling was located around the perimeter of the ubiquitin-positive labeling which occupied the central region of the neurite and Lewy body, with some overlap between MAP5 and ubiquitin staining. In contrast, in those Lewy bodies and neurites immunopositive for phosphorylated and non-phosphorylated neurofilament proteins, the neurofilament labeling was quite peripheral to the ubiquitin staining, with little or no overlap. Our results suggest MAP5 is more closely associated with the ubiquitinated proteins of Lewy bodies and neurites than other cytoskeletal proteins.
...
PMID:Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease. 877 50
Cortical dysplasia is a broad category for an abnormal structure of the cerebrum due to a disorder of the normal developmental process for neocortex. We investigated the cortical dysplastic lesions which were surgically resected from 4 patients with intractable epilepsy. All cases showed a derangement of the cortical laminar structure and dysplastic changes in the neurons. In addition, 3 of them showed large round cells (balloon cells) in the deep cortex and subcortical white matter. Since each lesion showed slightly different features, we further examined the lesions immunohistochemically by using a panel of antibodies against cytoskeletal proteins to recognize and classify the cortical dysplastic lesions. An immunohistochemical study revealed marked abnormalities of the cytoskeletal structures of dysplastic neurons, bizarre glial cells and balloon cells. These cells showed an accumulation of either phosphorylated NF,
MAP2
or GFAP in a distinct fashion.
Ubiquitin
immunoreactivity highlighted the extent of cortical dysplastic lesions. In a young patient, we also found the neuronal cytoplasmic lipofuscin deposition. It is thus considered that these diverse immunohistochemical appearances of cortical dysplasia may thus imply a different pathogenesis and they should therefore be classified based on the extent of histological abnormalities.
...
PMID:Abnormal cytoarchitecture of cortical dysplasia verified by immunohistochemistry. 956 32